DOI QR코드

DOI QR Code

Improved human hematopoietic reconstitution in HepaRG co-transplanted humanized NSG mice

  • Kim, Jin (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University) ;
  • Ryu, Bokyeong (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University) ;
  • Kim, Ukjin (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University) ;
  • Kim, Chang-Hwan (The 4th R&D Institute-6, Agency for Defense Development) ;
  • Hur, Gyeung-Haeng (The 4th R&D Institute-6, Agency for Defense Development) ;
  • Kim, C-Yoon (Stem Cell Biology, School of Medicine, Konkuk University) ;
  • Park, Jae-Hak (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University)
  • Received : 2019.12.14
  • Accepted : 2020.03.17
  • Published : 2020.09.30

Abstract

Several humanized mouse models are being used to study humanspecific immune responses and diseases. However, the pivotal needs of fetal tissues for the humanized mice model have been huddled because of the demand for ethical and medical approval. Thus, we have verified the hematopoietic and immunomodulatory function of HepaRG and developed a new and easy humanized mouse model to replace the use of fetal liver tissue. HepaRG co-transplanted Hu-NSG mice significantly increased CD45+ lymphocytes and CD19+ B cells and CD3+ T cells than normal Hu-NSG, suggesting enhanced reconstitution of the human immune system. These results have improved the applicability of humanized mice by developing new models easily accessible.

Keywords

References

  1. Lan P, Tonomura N, Shimizu A, Wang S and Yang YG (2006) Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood 108, 487-492
  2. Lavender KJ, Pang WW, Messer RJ et al (2013) BLThumanized C57BL/6 Rag2-/- ${\gamma}c$-/- CD47-/- mice are resistant to GVHD and develop B-and T-cell immunity to HIV infection. Blood 122, 4013-4020 https://doi.org/10.1182/blood-2013-06-506949
  3. Rongvaux A, Willinger T, Martinek J et al (2014) Development and function of human innate immune cells in a humanized mouse model. Nat Biotechnol 32, 364 https://doi.org/10.1038/nbt.2858
  4. Saito Y, Ellegast JM, Rafiei A et al (2016) Peripheral blood CD34+ cells efficiently engraft human cytokine knock-in mice. Blood 128, 1829-1833
  5. Shultz LD, Saito Y, Najima Y et al (2010) Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing $NOD/SCID/IL2r{\gamma}null$ humanized mice. Proc Natl Acad Sci U S A 107, 13022-13027 https://doi.org/10.1073/pnas.1000475107
  6. Klein F, Halper-Stromberg A, Horwitz JA et al (2012) HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature 492, 118 https://doi.org/10.1038/nature11604
  7. Yajima M, Imadome KI, Nakagawa A et al (2008) A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J Infect Dis 198, 673-682 https://doi.org/10.1086/590502
  8. Lan P, Tonomura N, Shimizu A, Wang S and Yang YG (2006) Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood 108, 487-492
  9. Fomin ME, Beyer AI and Muench MO (2017) Human fetal liver cultures support multiple cell lineages that can engraft immunodeficient mice. Open Biol 7, 170108 https://doi.org/10.1098/rsob.170108
  10. Guo J, Li Y, Shan Y et al (2018) Humanized mice reveal an essential role for human hepatocytes in the development of the liver immune system. Cell Death Dis 9, 667 https://doi.org/10.1038/s41419-018-0720-9
  11. Touraine JL (1983) Bone-Marrow and Fetal-Liver Transplantation in Immunodeficiencies and Inborn Errors of Metabolism: Lack of Significant Restriction of T-Cell Function in Long-Term Chimeras Despite HLA-Mismatch. Immunol Rev 71, 103-121 https://doi.org/10.1111/j.1600-065X.1983.tb01070.x
  12. Kapp MB (2006) Ethical and legal issues in research involving human subjects: do you want a piece of me? J Clin Pathol 59, 335-339 https://doi.org/10.1136/jcp.2005.030957
  13. Geraghty R, Capes-Davis A, Davis J et al (2014) Guidelines for the use of cell lines in biomedical research. Br J Cancer 111, 1021 https://doi.org/10.1038/bjc.2014.166
  14. Kubo T, Kuroda Y, Hojyo M et al (2016) Maintenance of hepatic progenitor-like characteristics of HepaRG cells by cultivation on VECELL Inserts. ALTEX 21, 71-79
  15. Parent R, Marion MJ, Furio L, Trepo C and Petit MA (2004) Origin and characterization of a human bipotent liver progenitor cell line. Gastroenterology 126, 1147-1156 https://doi.org/10.1053/j.gastro.2004.01.002
  16. Cerec V, Glaise D, Garnier D et al (2007) Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology 45, 957-967 https://doi.org/10.1002/hep.21536
  17. Mou F, Praskova M, Xia F et al (2012) The Mst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes. J Exp Med 209, 741-759 https://doi.org/10.1084/jem.20111692
  18. Clambey ET, McNamee EN, Westrich JA et al (2012) Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci U S A 109, E2784-2793 https://doi.org/10.1073/pnas.1202366109
  19. Qian Y, Kang Z, Liu C and Li X (2010) IL-17 signaling in host defense and inflammatory diseases. Cell Mol Immunol 7, 328-333 https://doi.org/10.1038/cmi.2010.27
  20. Tascher G, Burban A, Camus S et al (2019) In-Depth Proteome Analysis Highlights HepaRG Cells as a Versatile Cell System Surrogate for Primary Human Hepatocytes. Cells 8, 192 https://doi.org/10.3390/cells8020192
  21. Jabari S, Meissnitzer M, Quint K et al (2009) Cellular plasticity of trans- and dedifferentiation markers in human hepatoma cells in vitro and in vivo. Int J Oncol 35, 69-80
  22. Lu M, Kardel MD, O'Connor MD and Eaves CJ (2009) Enhanced generation of hematopoietic cells from human hepatocarcinoma cell-stimulated human embryonic and induced pluripotent stem cells. Exp Hematol 37, 924-936 https://doi.org/10.1016/j.exphem.2009.05.007
  23. Rangaraju S, Raza SA, Li NX et al (2018) Differential Phagocytic Properties of CD45(low) Microglia and CD45 (high) Brain Mononuclear Phagocytes-Activation and Age-Related Effects. Front Immunol 9, 405 https://doi.org/10.3389/fimmu.2018.00405
  24. Higuchi Y, Kawai K, Yamazaki H et al (2014) The human hepatic cell line HepaRG as a possible cell source for the generation of humanized liver TK-NOG mice. Xenobiotica 44, 146-153 https://doi.org/10.3109/00498254.2013.836257
  25. Audige A, Rochat MA, Li D et al (2017) Long-term leukocyte reconstitution in NSG mice transplanted with human cord blood hematopoietic stem and progenitor cells. BMC Immunol 18, 28 https://doi.org/10.1186/s12865-017-0209-9
  26. Ichii M, Oritani K, Yokota T et al (2010) Stromal cell-free conditions favorable for human B lymphopoiesis in culture. J Immunol Methods 359, 47-55 https://doi.org/10.1016/j.jim.2010.06.002